Tech Center 1600 • Art Units: 1644
This examiner grants 25% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17702439 | METHODS AND COMPOSITIONS FOR TREATING CANCER | Non-Final OA | President and Fellows of Harvard College |
| 17473083 | METHODS AND COMPOSITIONS FOR TREATING CANCER | Non-Final OA | President and Fellows of Harvard College |
| 19210620 | PSMA ANTIBODIES AND USES THEREOF | Non-Final OA | Wuxi Biologics Ireland Limited |
| 17691182 | Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody | Non-Final OA | Janssen Biotech, Inc. |
| 17599135 | ENGINEERED ANTIBODIES | Final Rejection | DANISCO US INC |
| 17771271 | ANTI-TSLP ANTIBODY AND USES THEREOF | Non-Final OA | HARBOUR BIOMED (SHANGHAI) CO., LTD. |
| 17422193 | SGLT-2 INHIBITORS OR IL-1R ANTAGONISTS FOR REDUCTION OF HYPOGLYCAEMIA AFTER BARIATRIC SURGERY | Final Rejection | UNIVERSITÄTSSPITAL BASEL |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy